. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4):395–403. doi: 10.1016/j.japh.2018.03.005

Table 2.

Study Exclusion Criteria and Rational

Exclusion Criteria	Rationale
Pregnancy	Given potential pre/post-natal opioid use complications among pregnant women/offspring
Psychotic and/or manic episode in the last 30 days	To ensure reliability of results and consistent contact/follow up
Filling buprenorphine only	Some formulations are not indicated for pain
Do not have a reliable landline or mobile phone	To ensure consistent contact/follow up
Cannot provide collateral contact information for ≥2 contact persons	To ensure consistent contact/follow up
Plan to leave the area for an extended period of time in the next 3 months	To ensure consistent contact/follow up